Peptide Purity Explained

Why “purity” can be misleading

The word “purity” is often presented as one percentage, but several different measurements may be involved.

A complete assessment may distinguish between:

• chromatographic purity;
• specified peptide-related impurities;
• unidentified impurities;
• peptide assay or content;
• water;
• residual solvents;
• counter-ions;
• inorganic residues;
• elemental impurities;
• microbiological attributes where relevant.

A result should state exactly what was tested and how it was calculated.

Chromatographic purity

Chromatographic purity is commonly measured using reversed-phase HPLC or UPLC.

The reported percentage often compares the integrated area of the main chromatographic peak with the total integrated area of detected peaks.

This is usually an area-normalisation result.

It describes the detector response under the stated method. It does not automatically describe the percentage by mass of the entire powder.

Peptide content or assay

Peptide content evaluates how much of the specified peptide is present.

A content result may be calculated:

• against a qualified reference standard;
• on an “as is” basis;
• on a dry basis;
• on an anhydrous basis;
• on a counter-ion-corrected basis;
• as peptide base.

The calculation basis must be stated because water, counter-ions and residual solvents can contribute to the total material mass.

Why 99% HPLC area does not necessarily mean 99% peptide by weight

A sample can show a large principal chromatographic peak while also containing components that are not measured by that particular detector or method.

Depending on the material, these may include:

• water;
• counter-ions;
• inorganic salts;
• residual solvents;
• volatile components;
• substances with weak detector response.

The correct interpretation is therefore:

“The principal detected chromatographic component represented the stated area percentage under the reported method.”

It should not automatically be interpreted as:

“The total powder consisted of the stated percentage of peptide by mass.”

Peptide-related impurities

Synthetic-peptide manufacture can generate structurally related impurities.

Examples include:

• deletion sequences;
• truncated sequences;
• incomplete coupling products;
• incompletely deprotected material;
• epimerised residues;
• oxidised variants;
• hydrolysed variants;
• deamidated variants;
• rearranged sequences;
• peptide aggregates;
• higher-molecular-weight material;
• process-related conjugation variants.

Some impurities may have chemical behaviour very similar to the intended peptide, making separation difficult.

Process-related non-peptide components

Manufacturing and purification may also leave non-peptide residues, depending on the process.

Possible categories include:

• synthesis reagents;
• cleavage reagents;
• purification solvents;
• counter-ions;
• buffer components;
• inorganic salts;
• residual water;
• elemental impurities.

Each category requires an appropriate analytical method. One HPLC chromatogram cannot rule out every type of residue.

Degradation products

Impurities can arise after synthesis through storage or handling.

Potential degradation pathways include:

• oxidation;
• hydrolysis;
• deamidation;
• rearrangement;
• aggregation;
• light-related change;
• temperature-related degradation.

A release result records the sample at the time of testing. Stability data are needed to justify a storage period or retest date.

Why method selectivity matters

An analytical procedure must be capable of distinguishing the intended peptide from relevant impurities.

Potential problems include:

• co-elution;
• insufficient run time;
• unsuitable detector wavelength;
• poor peak resolution;
• incorrect integration;
• sample overloading;
• unstable sample preparation;
• inadequate system suitability.

When one method cannot resolve the impurity profile adequately, a complementary method may be required.

What a useful purity specification may contain

Depending on the material, a specification may include:

• principal-component purity;
• limit for each specified impurity;
• limit for each unspecified impurity;
• total-impurity limit;
• peptide assay or content;
• water-content limit;
• residual-solvent limits;
• counter-ion range;
• elemental-impurity controls;
• appearance;
• identity;
• storage requirements.

The appropriate tests depend on the material, manufacturing process, intended experiment and identified risks.

A practical interpretation example

Suppose a report provides:

• HPLC area purity;
• an LC-MS identity result;
• a water-content result;
• a peptide-assay result.

These results answer different questions:

• HPLC: how the detected chromatographic peaks are distributed;
• LC-MS: whether the observed mass supports identity;
• water testing: how much water is present under that method;
• assay: how much specified peptide is measured under the stated calculation basis.

They should not be collapsed into one unqualified “purity” claim.